Demonstrates antibacterial efficacy of copper oxide nanoparticles in various temperatures, suggesting effective synthesis.
Fruit extract of Holarrhena antidysenterica served as a reducing agent for producing copper oxide nanoparticles (CuONPs). Thermal annealing was used to synthesize the nanoparticles at temperatures varying from 400°C to 800°C. Annealed CuONPs were subjected to structural and optical analyses using XRD, UV-Vis, HR-TEM, SEM, EDX, and FTIR. XRD and TEM measurements showed that the crystal size increased from 16.09 nm to 37.13 nm with increasing annealing temperature, along with enhanced crystallinity. UV-Vis absorption peaks between 250–300 nm showed a red shift from 250 nm to 287 nm, confirming temperature-dependent particle size control. The antibacterial effectiveness of synthesized CuONPs was tested against Escherichia coli , Staphylococcus aureus , and Salmonella enterica . The CuONP400 sample exhibited the highest zone of inhibition, measuring 18 mm against E. coli, 14 mm against S. aureus , and no activity against S. enterica . These findings demonstrate that the synthesized CuONPs exhibit significant antimicrobial effectiveness, with synergistic effects observed across different annealing temperatures.
No takes yet. Share an insight, caveat, or question.
Akhter et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: